source
- FDA issues first AI-focused cGMP warning letter, flagging oversight gaps for manufacturersThe FDA has issued its first warning letter that explicitly addresses the use of artificial intelligence in pharmaceutical manufacturing, targeting Purolea Cosmetics Lab. The letter cites AI‑gener…
- Three biotech firms launch IPOs to challenge giants in cardiometabolic and immunology marketsBraveheart Bio, Attovia Therapeutics and Vogenx filed for initial public offerings this week, adding to a surge of biotech listings in 2026. Braveheart is developing a therapy for hypertrophic car…